• Explore /
  • Poster
  • / Analysis of early tumor shrinkage (ETS) and depth of response (DpR) in metastatic colorectal cancer (mCRC) patients (pts) treated with second-line FOLFIRI plus panitumumab (Pani) or bevacizumab (Bev): Results from a randomized phase II WJOG6210G trial.

Analysis of early tumor shrinkage (ETS) and depth of response (DpR) in metastatic colorectal cancer (mCRC) patients (pts) treated with second-line FOLFIRI plus panitumumab (Pani) or bevacizumab (Bev): Results from a randomized phase II WJOG6210G trial.

Abstract Poster

Authors

null

Naoki Izawa

St. Marianna University School of Medicine, Kawasaki, Japan

Naoki Izawa , Kohei Shitara , Toshiki Masuishi , Tadamichi Denda , Kentaro Yamazaki , Toshikazu Moriwaki , Hiroyuki Okuda , Chihiro Kondoh , Tomohiro Nishina , Akitaka Makiyama , Hideo Baba , Hironori Yamaguchi , Masato Nakamura , Akihito Tsuji , Taito Esaki , Yoshinori Miyata , Masahito Kotaka , Takeharu Yamanaka , Takako Eguchi Nakajima , Kei Muro

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Anal and Colorectal Cancer

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

UMIN000031621

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 201)

Abstract #

201

Poster Bd #

K1

Abstract Disclosures

Similar Posters

First Author: Naoki Izawa

First Author: Eiji Shinozaki

First Author: Kohei Shitara

First Author: B. Chibaudel